A detailed history of Tbh Global Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Tbh Global Asset Management, LLC holds 2,174 shares of LLY stock, worth $1.73 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
2,174
Previous 1,974 10.13%
Holding current value
$1.73 Million
Previous $1.79 Million 7.78%
% of portfolio
0.43%
Previous 0.4%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$772.14 - $960.02 $154,428 - $192,004
200 Added 10.13%
2,174 $1.93 Million
Q2 2024

Aug 02, 2024

SELL
$724.87 - $909.04 $34,068 - $42,724
-47 Reduced 2.33%
1,974 $1.79 Million
Q1 2024

May 08, 2024

BUY
$592.2 - $792.28 $117,847 - $157,663
199 Added 10.92%
2,021 $1.57 Million
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $130,772 - $154,163
249 Added 15.83%
1,822 $1.06 Million
Q3 2023

Oct 31, 2023

BUY
$434.7 - $599.3 $83,897 - $115,664
193 Added 13.99%
1,573 $844,000
Q2 2023

Jul 20, 2023

BUY
$350.74 - $468.98 $76,110 - $101,768
217 Added 18.66%
1,380 $647,000
Q1 2023

May 08, 2023

BUY
$310.63 - $364.82 $118,039 - $138,631
380 Added 48.53%
1,163 $399,000
Q4 2022

Feb 10, 2023

SELL
$321.55 - $374.67 $32,155 - $37,467
-100 Reduced 11.33%
783 $286,000
Q3 2022

Nov 07, 2022

BUY
$296.48 - $337.87 $261,791 - $298,339
883 New
883 $286,000
Q1 2022

May 11, 2022

SELL
$234.69 - $291.66 $406,013 - $504,571
-1,730 Closed
0 $0
Q4 2020

Feb 04, 2021

SELL
$130.46 - $172.63 $2,348 - $3,107
-18 Reduced 1.03%
1,730 $292,000
Q3 2020

Nov 09, 2020

SELL
$146.22 - $169.13 $2.48 Million - $2.87 Million
-16,969 Reduced 90.66%
1,748 $259,000
Q2 2020

Jul 23, 2020

BUY
$136.42 - $164.18 $2.55 Million - $3.07 Million
18,717 New
18,717 $3.07 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tbh Global Asset Management, LLC Portfolio

Follow Tbh Global Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tbh Global Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tbh Global Asset Management, LLC with notifications on news.